Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis: Results from the Open-Label Period of a Phase 3 TrialDinesh Khanna,Celia J. F. Lin,Helen Spotswood,Jeffrey Siegel,Daniel Furst,Christopher DentonARTHRITIS & RHEUMATOLOGY（2020）引用 5|浏览23暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
